Rheumatoid arthritis and Gastroenteritis clostridial

Summary:

Gastroenteritis clostridial is found among people with Rheumatoid arthritis, especially for people who are female, 60+ old.

The study analyzes which people have Gastroenteritis clostridial with Rheumatoid arthritis. It is created by eHealthMe based on reports of 29 people who have Rheumatoid arthritis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 07, 2023

29 people who have Rheumatoid Arthritis and Gastroenteritis Clostridial are studied.


What is Rheumatoid arthritis?

Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 2,778 drugs and 1,985 conditions by eHealthMe.

What is Gastroenteritis clostridial?

Gastroenteritis clostridial (inflammation of stomach and intestine clostridial) is found to be associated with 297 drugs and 182 conditions by eHealthMe.

Number of Gastroenteritis clostridial in Rheumatoid arthritis reports submitted per year:

Would you have Gastroenteritis clostridial when you have Rheumatoid arthritis?

Gender of people who have Rheumatoid Arthritis and experienced Gastroenteritis Clostridial *:

  • female: 79.31 %
  • male: 20.69 %

Age of people who have Rheumatoid Arthritis and experienced Gastroenteritis Clostridial *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs taken by these people *:

  1. Humira: 6 people, 20.69%
  2. Cimzia: 5 people, 17.24%
  3. Simvastatin: 3 people, 10.34%
  4. Voltaren: 3 people, 10.34%
  5. Topamax: 3 people, 10.34%
  6. Heparin: 2 people, 6.90%
  7. Advair Diskus 100/50: 2 people, 6.90%
  8. Atrovent: 2 people, 6.90%
  9. Tylenol W/ Codeine No. 3: 2 people, 6.90%
  10. Diclofenac Sodium: 2 people, 6.90%

Common symptoms for these people *:

  1. Idiopathic Pulmonary Fibrosis (chronic lung disease): 11 people, 37.93%
  2. Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 11 people, 37.93%
  3. Pneumonia: 9 people, 31.03%
  4. Osteoporosis (bones weak and more likely to break): 8 people, 27.59%
  5. Nasopharyngitis (inflammation of the nasopharynx): 8 people, 27.59%
  6. Episcleritis (acute inflammatory disorder of the episclera of eye): 8 people, 27.59%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 24.14%
  8. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 24.14%
  9. Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 24.14%
  10. Acute Kidney Failure: 5 people, 17.24%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastroenteritis clostridial?

Check whether Gastroenteritis clostridial is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Gastroenteritis clostridial:

All the drugs that are associated with Gastroenteritis clostridial:

All the conditions that are associated with Gastroenteritis clostridial:

How the study uses the data?

The study is based on Gastroenteritis clostridial and Rheumatoid arthritis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: